| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $349.7M | -0.2% |
| Cost of Revenue | $70.6M | +1.3% |
| Gross Profit | $279.1M | -0.6% |
| R&D Expense | $7.5M | -2.9% |
| SG&A Expense | $69.8M | -3.7% |
| Operating Income | $150.2M | +0.6% |
| Pre-tax Income | $114.0M | -6.7% |
| Income Tax | $29.5M | -10.1% |
| Net Income | $84.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.7M | +122.6% |
| Accounts Receivable | $23.7M | -5.0% |
| Current Assets | $117.2M | +57.2% |
| Total Assets | $663.8M | +10.2% |
| Current Liabilities | $65.5M | -17.4% |
| Long-term Debt | $558.4M | -5.8% |
| Total Liabilities | $650.0M | -4.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $136.1M | +11.8% |
| Capital Expenditures | $30.2M | -9.6% |
| Investing Cash Flow | -$35.2M | -5.4% |
| Financing Cash Flow | -$63.3M | +54.3% |
| Free Cash Flow | $105.9M | +19.9% |
| -5.5% |
| EPS (Basic) | $4.39 | -5.4% |
| EPS (Diluted) | $4.35 | -5.8% |
| Stockholders' Equity |
| $13.8M |
| +117.3% |